BIOX Bioceres Crop Solutions Corp

  1. Stocks
  2. Basic Materials
  3. NASDAQ: BIOX

Price (delayed)

$11.66

Market cap

$732.57M

P/E Ratio

33.31

Dividend/share

N/A

EPS

$0.35

Enterprise value

$944.81M

bioceres crop solutions corp., together with its subsidiaries, provides crop productivity solutions. the company operates through three segments: seed and integrated products, crop protection, and crop nutrition. the seed and ...

Highlights
Bioceres Crop Solutions's EPS has soared by 188% YoY and by 59% from the previous quarter
The net income has soared by 60% from the previous quarter
Bioceres Crop Solutions's quick ratio has decreased by 4.5% YoY but it has increased by 3.7% QoQ
Sector: Basic Materials
Industry: Agricultural Inputs
Website: https://biocerescrops.com/
Peers: SMG

Key stats

What are the main financial stats of BIOX
Market
Shares outstanding
62.83M
Market cap
$732.57M
Enterprise value
$944.81M
Valuations
Price to earnings (P/E)
33.31
Price to book (P/B)
2.44
Price to sales (P/S)
1.63
EV/EBIT
16.93
EV/EBITDA
12.6
EV/Sales
2.1
Earnings
Revenue
$450.32M
EBIT
$55.81M
EBITDA
$74.96M
Free cash flow
$6.78M
Per share
EPS
$0.35
Free cash flow per share
$0.11
Book value per share
$4.78
Revenue per share
$7.17
TBVPS
$8.51
Balance sheet
Total assets
$819.52M
Total liabilities
$484.26M
Debt
$236.64M
Equity
$300.54M
Working capital
$75.18M
Liquidity
Debt to equity
0.79
Current ratio
1.24
Quick ratio
0.85
Net debt/EBITDA
2.83
Margins
EBITDA margin
16.6%
Gross margin
42%
Net margin
4.9%
Operating margin
11.8%
Efficiency
Return on assets
2.7%
Return on equity
7.3%
Return on invested capital
12.7%
Return on capital employed
11.1%
Return on sales
12.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BIOX stock price

How has the Bioceres Crop Solutions stock price performed over time
Intraday
-1.19%
1 week
-2.18%
1 month
-7.61%
1 year
4.39%
YTD
-15.08%
QTD
-7.9%

Financial performance

How have Bioceres Crop Solutions's revenue and profit performed over time
Revenue
$450.32M
Gross profit
$189.36M
Operating income
$53.23M
Net income
$21.96M
Gross margin
42%
Net margin
4.9%
The operating income has soared by 76% YoY and by 31% from the previous quarter
The net income has soared by 60% from the previous quarter
BIOX's operating margin has soared by 55% YoY and by 17% QoQ
BIOX's net margin is up by 44% since the previous quarter

Growth

What is Bioceres Crop Solutions's growth rate over time

Valuation

What is Bioceres Crop Solutions stock price valuation
BIOX P/E details
P/E
33.31
P/B
2.44
P/S
1.63
EV/EBIT
16.93
EV/EBITDA
12.6
EV/Sales
2.1
Bioceres Crop Solutions's EPS has soared by 188% YoY and by 59% from the previous quarter
The stock's price to earnings (P/E) is 30% less than its last 4 quarters average of 47.6
BIOX's P/B is 42% lower than its 5-year quarterly average of 4.2 and 6% lower than its last 4 quarters average of 2.6
The equity has grown by 10% YoY
BIOX's P/S is 14% below its last 4 quarters average of 1.9 and 4.1% below its 5-year quarterly average of 1.7
The company's revenue rose by 14% YoY and by 12% QoQ

Efficiency

How efficient is Bioceres Crop Solutions business performance
The ROA has soared by 193% YoY and by 69% QoQ
BIOX's return on equity has surged by 173% year-on-year and by 55% since the previous quarter
Bioceres Crop Solutions's ROS has soared by 75% YoY and by 18% from the previous quarter
BIOX's return on invested capital has surged by 69% year-on-year and by 32% since the previous quarter

Dividends

What is BIOX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BIOX.

Financial health

How did Bioceres Crop Solutions financials performed over time
BIOX's total assets is 69% higher than its total liabilities
BIOX's total liabilities is down by 14% YoY
Bioceres Crop Solutions's current ratio has decreased by 9% YoY and by 2.4% from the previous quarter
BIOX's debt is 21% smaller than its equity
Bioceres Crop Solutions's debt to equity has decreased by 20% YoY
BIOX's debt is down by 13% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.